Key Takeaways
- IBM shares declined more than 4% in early Thursday trading following Accenture’s fiscal 2026 revenue guidance reduction
- Accenture revised its annual sales forecast to $71.76B–$72.46B, lowering the upper range from $73.16B
- While Accenture’s Q3 EPS of $3.80 exceeded projections, quarterly sales of $18.7B fell short of the $18.745B analyst consensus
- According to GF Value metrics, IBM trades approximately 9.9% above fair value at $262.35, carrying a GF Score of 78/100
- IBM’s Q2 earnings release is scheduled for July 22, with Wall Street forecasting EPS of $3.00 and sales of $17.85B
Shares of International Business Machines took a significant hit Thursday morning as Accenture’s revised fiscal 2026 revenue forecast created turbulence throughout the IT services industry.
International Business Machines Corporation, IBM
In premarket action, IBM traded at $251.01, representing a 4.32% decline. The stock had already retreated 3.1% during Tuesday’s regular session to close at $262.35 on June 17.
The sharp downturn wasn’t driven by IBM’s own fundamentals or announcements. Rather, market participants reacted negatively to revised projections from Accenture.
Accenture adjusted its full-year sales guidance to a corridor of $71.763 billion through $72.460 billion. This represents a meaningful reduction from the prior upper target of $73.157 billion. Analyst expectations had been pegged at $74.006 billion for the fiscal year.
This type of forecast adjustment typically creates a domino effect throughout sector comparables — and IBM became a casualty of that dynamic.
Despite the guidance adjustment, Accenture delivered positive news on profitability. Third-quarter diluted EPS reached $3.80, surpassing the $3.69 analyst forecast. However, quarterly sales of $18.700 billion narrowly trailed the $18.745 billion consensus estimate, and the forward-looking guidance cut overshadowed the earnings beat.
Accenture CEO Julie Sweet emphasized robust artificial intelligence demand, highlighting 104 client contracts valued at $100 million or greater year-to-date, representing a 13% increase. The firm also revealed intentions to acquire majority ownership in Dragos while purchasing all of runZero and NetRise, focusing on operational technology cybersecurity opportunities.
IBM’s Q2 Results Set for July 22 Release
IBM’s quarterly financial results are scheduled for July 22. Wall Street consensus calls for EPS of $3.00 alongside revenue of $17.85 billion for the second quarter.
During the first quarter, IBM delivered EPS of $1.91, exceeding the $1.81 analyst estimate. Sales totaled $15.92 billion, topping the $15.66 billion consensus projection. This performance extended IBM’s earnings beat streak to eight consecutive quarters — a record investors will monitor closely with the upcoming report.
Current Valuation Analysis
According to GuruFocus metrics, IBM’s GF Value stands at $238.63, indicating the stock commanded approximately a 9.9% premium relative to that fair value assessment at $262.35.
IBM’s present P/E ratio of 23.2x registers marginally below its five-year median of 24.4x. The forward-looking P/E ratio stands at 21.1x.
The company’s GF Score of 78/100 suggests above-average standing among industry peers, with profitability representing the most robust element at 8/10. Financial strength registers at 5/10, while momentum scores 4/10 — the latter aligning with Thursday’s price movement.
Notably, insider transaction data shows no recorded activity over the previous three-month period.
IBM’s 52-week trading range extends from $212.34 to $332.46, positioning Thursday’s premarket level of $251.01 toward the lower portion of that spectrum.
The company’s next significant market-moving event arrives July 22.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
